|
|
Article: Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.(Study protocol)(Report)
- Article from:
- BMC Family Practice
- Article date:
- October 20, 2008
- Author:
CopyrightCOPYRIGHT 2008 BioMed Central Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Authors: Cindy MA de Bot (corresponding author) [1]; Heleen Moed [1]; Marjolein Y Berger [1]; Esther R
öder [1,2]; Hans de Groot [2]; Johan C de Jongste [3]; Roy Gerth van Wijk [2]; Johannes C van der Wouden [1]
Background
Specific immunotherapy with allergens might prevent the onset of asthma in individuals with allergic rhinitis and may accelerate the remission of asthma in children with allergic disease. [1, 2, 3] Although subcutaneous immunotherapy (SCIT) is an effective treatment of respiratory allergic disorders, [4] the injections can be uncomfortable and side effects, though rare, may be serious and even fatal. [5, 6] The use of ...
Related newspaper, magazine, and journal articles:
|